Prediagnostic prescription patterns in multiple sclerosis: a UK-based longitudinal linked data study

BACKGROUND: Early detection of multiple sclerosis (MS) could improve patient outcomes. Changes in clinical activity before MS diagnosis may represent 'diagnostic windows' for earlier detection. AIM: To determine whether certain prescriptions are more common in patients with MS and examine prescription patterns prediagnosis in the UK. DESIGN AND SETTING: Case-control study using routinely collected primary care data. Patients in the case group had an MS diagnosis (2001-2022) and patients in the control group were matched by birth year. METHOD: Multivariable conditional logistic regression adjusting for sex and socioeconomic status (SES) examined associations between MS diagnosis and prescriptions for anxiety/depression, migraine, lower urinary tract symptoms (LUTS), urinary tract infection (UTI) treatments, sleep disorder, gastrointestinal (GI) symptoms, and erectile dysfunction (ED) in the 0-2, 2-5, 5-10 years prediagnosis/match date. Poisson regression adjusting for age, sex, and SES estimated the inflection points in the case group at which the rate of prescriptions changed from baseline, identifying the start of diagnostic windows. RESULTS: In total, there were 9662 patients in the case group and 56 455 in the control group. Positive associations were found between seven prescriptions and MS diagnosis, with highest odds ratios (3-7 times) in the 2 years prediagnosis. In the all-prescription analysis, inflection points were identified for: GI (69-72 months, 95% confidence interval [CI] = 51 to 90), LUTS (69-72 months, 95% CI = 30 to 111), UTI (66-69 months, 95% CI = 45 to 90), migraine (63-66 months, 95% CI = 27 to 102), ED (60-63 months, 95% CI = 30 to 93), and anxiety/depression (9-12 months, 95% CI = 3 to 18). CONCLUSION: Prescriptions for symptoms of possible MS were more common in the case group than the control group up to 10 years prediagnosis. Prescription rates changed years prediagnosis, indicating potential opportunities for earlier detection, but broad CIs demonstrated uncertainty regarding diagnostic window duration.

Authors

Institutions

Publication Details

Journal
British Journal of General Practice
Published
2026-04-20
DOI
https://doi.org/10.3399/bjgp.2025.0210
Primary Topic
Multiple Sclerosis Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Prediagnostic prescription patterns in multiple sclerosis: a UK-based longitudinal linked data study

Ruth Dobson, Garth Funston, Oleg B. Blyuss, Kirsten D. Arendse et al.
British Journal of General Practice
Multiple Sclerosis Research Studies
article

Prediagnostic prescription patterns in multiple sclerosis: a UK-based longitudinal linked data study

Ruth Dobson, Garth Funston, Oleg B. Blyuss, Kirsten D. Arendse, Luke TA Mounce, Baoyue Zhang
article en

Abstract

BACKGROUND: Early detection of multiple sclerosis (MS) could improve patient outcomes. Changes in clinical activity before MS diagnosis may represent 'diagnostic windows' for earlier detection. AIM: To determine whether certain prescriptions are more common in patients with MS and examine prescription patterns prediagnosis in the UK. DESIGN AND SETTING: Case-control study using routinely collected primary care data. Patients in the case group had an MS diagnosis (2001-2022) and patients in the control group were matched by birth year. METHOD: Multivariable conditional logistic regression adjusting for sex and socioeconomic status (SES) examined associations between MS diagnosis and prescriptions for anxiety/depression, migraine, lower urinary tract symptoms (LUTS), urinary tract infection (UTI) treatments, sleep disorder, gastrointestinal (GI) symptoms, and erectile dysfunction (ED) in the 0-2, 2-5, 5-10 years prediagnosis/match date. Poisson regression adjusting for age, sex, and SES estimated the inflection points in the case group at which the rate of prescriptions changed from baseline, identifying the start of diagnostic windows. RESULTS: In total, there were 9662 patients in the case group and 56 455 in the control group. Positive associations were found between seven prescriptions and MS diagnosis, with highest odds ratios (3-7 times) in the 2 years prediagnosis. In the all-prescription analysis, inflection points were identified for: GI (69-72 months, 95% confidence interval [CI] = 51 to 90), LUTS (69-72 months, 95% CI = 30 to 111), UTI (66-69 months, 95% CI = 45 to 90), migraine (63-66 months, 95% CI = 27 to 102), ED (60-63 months, 95% CI = 30 to 93), and anxiety/depression (9-12 months, 95% CI = 3 to 18). CONCLUSION: Prescriptions for symptoms of possible MS were more common in the case group than the control group up to 10 years prediagnosis. Prescription rates changed years prediagnosis, indicating potential opportunities for earlier detection, but broad CIs demonstrated uncertainty regarding diagnostic window duration.

British Journal of General PracticeVol. 76(766)
Queen Mary University of London (GB), Sechenov University (RU), Barts Health NHS Trust (GB), University of Exeter (GB), Royal London Hospital (GB)
Openalex Percentile: Top 20%
Multiple Sclerosis Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.